A bill introduced in Oklahoma would not only bar doctors from prescribing transition-related health care treatments to youth suffering from gender dysphoria, but would criminalize any medical provider who prescribes such treatments to adults in their late teens and twenties.
The measure, introduced by Sen. David Bullard (R-Durant), would make any physician who prescribes gender-affirming treatments for gender dysphoria to anyone under the age of 26 — or who refers a patient to a medical professional who provides such treatments — guilty of a felony.
The law would allow doctors who prescribe such treatments to be prosecuted for up to 40 years after prescribing the treatments, and would allow anyone who undergoes such treatments but later experiences regret to sue within that same 40-year time period.
Additionally, the law would deem prescribing any such procedures or treatments as “unprofessional conduct” that would result in the loss of the doctor’s license to practice.
The bill would bar public funds from being granted to any organization that provides such procedures to anyone under the age of 26, and gender-affirming treatments — whether puberty blockers, hormone therapy, or gender confirmation surgery — could not be performed in any facility owned by the state or a local government, or recommended by any physician or health care professional who is employed by the state or a local government.
As is common with most bills barring gender-affirming care, the bill grants an exemption for doctors to recommend surgery or other procedures that seek to force intersex individuals to alter their bodies in order to conform to a specific assigned sex. Additionally, there is an exemption for doctors treating people who have experienced complications from undergoing transition-related care, and another exemption that would allow certain procedures, such as a hysterectomy, that are needed to treat a disorder or illness that would otherwise place the patient at risk of death or serious injury.
“The bill is a restriction on transgender medicine and procedures just making sure that we have it restricted to an age where cognitive development is mature,” Bullard, who is a teacher by profession, told Oklahoma City-based CBS affiliate KWTV. “The brain is not fully developed until 25.”
Billard previously authored a bill last year that became law, requiring all restrooms and changing rooms in public schools to be expressly designated for a specific biological sex.
A separate, but similar, bill filed by State Rep. Jim Olsen (R-Sallisaw) last year would bar physicians from providing gender-affirming treatments to any patient under the age of 21, carrying a penalty of a $100,000 fine and up to a decade in prison for any violations.
Bullard noted that doctors who prescribe gender-affirming care to individuals who are otherwise legally recognized as adults have a lot to lose by violating the law, endangering their ability to practice and opening themselves up to lawsuits from former patients.
“Their Hippocratic oath…was ‘to do no harm’ and so that is what this surgery or these procedures do,” Bullard said.
Critics of the bill say that the bill’s penalties will effectively inhibit any practicing physician from recommending any gender-affirming treatments, and could lead some to refuse to treat transgender individuals altogether — effectively leaving those suffering from gender dysphoria on their own.
“We know things like puberty blockers can have a dramatic difference in someone’s ability to stay alive. To disrupt suicidality if they are a transgender young person,” Nicole McAfee, the executive director of Freedom Oklahoma, told KWTV.
“There is a lot of debate about different ages, [but] any of these bans are harmful,” added McAfee. “What we are talking about is an expansion of the Oklahoma legislature choosing to disrupt best practice medical care in this case for transgender people.”
A recent study of injectable pre-exposure prophylaxis found that twice-yearly injections of lenacapavir -- marketed as Yeztugo by Gilead Sciences -- do not have clinically significant interactions with gender-affirming hormone therapy.
"In the most gender-diverse Phase III PrEP trial conducted to date, lenacapavir had no clinically significant impact on feminizing or masculinizing gender-affirming therapy concentrations," the study’s researchers concluded, as reported by POZ.
The study, led by Dr. Jill Blumenthal of the University of California San Diego, examined whether lenacapavir interacts with gender-affirming hormone therapy, including estradiol (a form of estrogen) and testosterone. Because those hormones are metabolized by enzymes such as CYP3A4 -- which lenacapavir can inhibit -- the researchers analyzed whether the drug altered hormone levels.
The Trump administration is working to bring a transgender woman back to the United States after immigration officials wrongly deported her in violation of a federal judge's order.
Britania Uriostegui Rios, a Mexican transgender woman who came to the U.S. in 2003 and later became a lawful permanent resident, lost that status in 2023 after pleading guilty to felony assault with a deadly weapon, according to The Guardian.
She received a suspended sentence for the assault conviction, then was sent to a men's immigration detention facility as officials prepared to deport her to Mexico.
In a letter to House Speaker Mike Johnson (R-La.), 213 Democratic U.S. representatives, as well as Delegates Stacey Plaskett (Virgin Islands), Eleanor Holmes Norton (D.C.), and Resident Commissioner Pablo José Hernández (Puerto Rico), are demanding that Johnson rebuke Republican lawmakers for using "demonizing and dehumanizing" language when speaking about the transgender community.
"We write to you to strongly condemn the rise in anti-transgender rhetoric, including from members of Congress, and to urge you to ensure members of Congress are following rules of decorum and not using their platforms to demonize and scapegoat any marginalized community, including the transgender community," the Democrats' letter reads.
These are challenging times for news organizations. And yet it’s crucial we stay active and provide vital resources and information to both our local readers and the world. So won’t you please take a moment and consider supporting Metro Weekly with a membership? For as little as $5 a month, you can help ensure Metro Weekly magazine and MetroWeekly.com remain free, viable resources as we provide the best, most diverse, culturally-resonant LGBTQ coverage in both the D.C. region and around the world. Memberships come with exclusive perks and discounts, your own personal digital delivery of each week’s magazine (and an archive), access to our Member's Lounge when it launches this fall, and exclusive members-only items like Metro Weekly Membership Mugs and Tote Bags! Check out all our membership levels here and please join us today!
You must be logged in to post a comment.